The absence of surgical outcome data limits risk quantification, but the systemic endocrine activity of these agents warrants heightened perioperative caution
GLP-1 agonists may exacerbate the muscle strength decline associated with sarcopenia, an age-related condition characterized by loss of muscle mass, strength, and function, thereby compromising balance, increasing fall risk, and eroding independence
The BCBS FEP program, which covers federal employees, generally offers the most comprehensive weight loss medication coverage within the BCBS system
Rocky Mountain IV Medics is a leading IV therapy service provider
Insurance plans may cover Wegovy for cardiovascular risk reduction and MASH treatment even if they dont cover Wegovy for weight loss